MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
Recruiting · NCT04572256 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, arthritic joint disease, arthropathy, injury, musculoskeletal system disorder, osteoarthritis, rheumatic disorder | Recruiting | Early phase 1 | 2026-06-10 | NCT04572256 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Austin V Stone | 1 |
| Duke University | 446 |
| The Cleveland Clinic | 239 |
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UK Healthcare at Turfland | Lexington | United States | 2 |